Jazz Pharmaceuticals Plc
(NASDAQ : JAZZ)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
Loading JAZZ News...
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
-3.26%15.128.4%$330.32m
SHPGShire PLC Sponsored ADR
-4.26%165.410.5%$204.37m
MNKMallinckrodt Plc
-3.95%51.607.1%$160.69m
PRGOPerrigo Co. Plc
-0.73%83.853.7%$143.34m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-3.91%115.4911.4%$81.66m
ENDPEndo International Plc
-4.98%15.075.9%$78.47m
PRXLPAREXEL International Corporation
1.49%63.555.8%$73.46m
UTHRUnited Therapeutics Corporation
-3.64%131.7620.3%$72.86m
JAZZJazz Pharmaceuticals Plc
-1.60%102.222.7%$68.49m
HZNPHorizon Pharma plc
-3.27%19.5510.8%$62.19m
MDCOMedicines Company
-3.36%33.3816.6%$51.27m
ICPTIntercept Pharmaceuticals, Inc.
-2.52%103.1719.0%$50.21m
ICLRICON Plc
-0.18%76.234.1%$39.78m
DEPODepomed, Inc.
-0.65%19.8519.2%$37.32m
PCRXPacira Pharmaceuticals, Inc.
2.03%32.6513.6%$32.22m

Company Profile

Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products. It has a diverse portfolio of products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded by Bruce C. Cozadd on January 18, 2012 and is headquartered in Dublin, Ireland.